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Abstract
Background: Complications of idiopathic intracranial hypertension (IIH) are usually caused by elevated intracranial pressure
(ICP). In a similar way as in the optic nerve, elevated ICP could also compromise the olfactory nerve system. On the other
side, there is growing evidence that an extensive lymphatic network system around the olfactory nerves could be disturbed
in cerebrospinal fluid disorders like IIH. The hypothesis that patients with IIH suffer from hyposmia has been suggested in
the past. However, this has not been proven in clinical studies yet. This pilot study investigates whether structural changes
of the olfactory nerve system can be detected in patients with IIH.
Methodology/Principal Findings: Twenty-three patients with IIH and 23 matched controls were included. Olfactory bulb
volume (OBV) and sulcus olfactorius (OS) depth were calculated by magnetic resonance techniques. While mean values of
total OBV (128.7638.4 vs. 130.0632.6 mm
3, p=0.90) and mean OS depth (8.561.2 vs. 8.661.1 mm, p=0.91) were similar in
both groups, Pearson correlation showed that patients with a shorter medical history IIH revealed a smaller OBV (r=0.53,
p,0.01). In untreated symptomatic patients (n=7), the effect was greater (r=0.76, p,0.05). Patients who suffered from IIH
for less than one year (n=8), total OBV was significantly smaller than in matched controls (116.6624.3 vs. 149.3622.2 mm
3,
p=0.01). IIH patients with visual disturbances (n=21) revealed a lower OS depth than patients without (8.360.9 vs.
10.861.0 mm, p,0.01).
Conclusions/Significance: The results suggest that morphological changes of the olfactory nerve system could be present
in IIH patients at an early stage of disease.
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Introduction
Idiopathic intracranial hypertension (IIH) is characterized by
increased intracranial pressure (ICP) and is affecting mainly obese
women of childbearing age. The aetiology of the disorder is not
well understood but disturbed cerebrospinal fluid (CSF) dynamics
are assumed to be an important factor. Affected patients mostly
suffer from chronic disabling headache and other symptoms of
elevated ICP like visual disturbance, tinnitus and diplopia.
Impairment of visual function is often progressive and permanent
in up to 25% of all cases [1,2,3].
Similar to the optic nerve, the olfactory nerve (ON) is covered
by a meningeal sheath enclosing the subarachnoidal space.
Elevated intracranial pressure (ICP) is a characteristic feature of
IIH and could damage the olfactory nerves (ONs) directly by
mechanical impact. There are also case reports about nasal liquor
leakage in IIH patients [4,5]. The authors argue that an increased
ICP may break the nerve sheaths around the olfactory nerves that
allow for liquor passage via the cribriform plate. In addition, there
is growing evidence that an extensive lymphatic network system
around the ONs could play a role in CSF absorption. The
pathway of CSF absorption leads along the ONs and the
absorbing acting system is located in the submucosal space
associated with the nasal olfactory and respiratory epithelium [6].
The hypothesis that patients with IIH suffer from hyposmia has
been suggested by Kapoor [7]. Giuseffi and colleagues reported
that up to 25% of IIH patients complain about decreased smell
[8]. This assumption is clinically relevant, since undetected and
therefore untreated olfactory disorders are associated with reduced
quality of life and problems with daily life situations [9,10].
Furthermore, patients with hyposmia are at higher risk to develop
depression [11]. However, to the best of our knowledge, clinical
studies investigating the ON system in patients with IIH have not
been reported in the literature.
Decreased olfactory function is mostly associated with reduced
olfactory bulb volume (OBV) [12,13,14,15]. Buschhu ¨ter et al.
investigated a large cohort of normal volunteers and defined
normative values for minimal-normal OBV as 58 mm
3 in people
,45 years and as 46 mm
3 in people .45 years [15]. The
importance of the determination of the depth of olfactory sulcus
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between reduced olfactory function and smaller depth of OS in
patients with olfactory dysfunction since birth or early childhood
[16]. Wang and colleagues have demonstrated that the OS depth
is reduced in patients with Parkinson disease [17].
The aim of our pilot study was to investigate OBV and OS
depth to verify if the ON system is affected in IIH.
Methods
Patients fulfilling the modified Dandy criteria for IIH [18] and
an age over 18 years were screened using the hospital’s electronic
medical records system. Patients with any secondary cause of
intracranial hypertension were not eligible for inclusion in the
study. Screening period was from November 2005 until May
2010. Approval for this study was obtained from the institutional
ethics committee (Ethikausschuss 1, Charite ´ Campus Mitte).
Written informed consent was obtained from all participants
before enrolment in the study. All clinical investigations have been
conducted according to the principles expressed in the Declaration
of Helsinki. Seventy-one patients were potentially eligible to be
included in the study. Altogether 15 patients were excluded by the
exclusion criteria shunt surgery (n=6), body weight over 180 kg
(n=3), pregnancy (n=1), and magnetic resonance imaging (MRI)
phobia (n=4). One patient fulfilled the criteria for major
depression (diagnosed by the Becks Depression Inventory and
Hamilton Rating Scale for Depression) and was excluded.
Eighteen patients could not be reached by phone, eight patients
refused because effort of participation in the study was too high for
them, and seven subjects objected to participation without
specifying any reasons. All participants underwent clinical
examination to detect olfactory disorders with a different genesis
(e.g. post-infectious, post-traumatic, current sinunasal or upper
respiratory tract infections, tumors treated with radiation or
chemotherapy, allergies, depression) at the Special Consulting
Service for Olfactory Disorders at the ENT-Department of the
Charite ´ University in Berlin, Germany. Altogether, 23 patients
could be included in the study.
Each patient with IIH was matched with a control patient for
sex, age and body mass index (BMI). Controls were selected from a
local obesity center and from the hospital staff. Subjects with
known history of CNS disease or episodes of continuous or
recurring headache syndromes were not eligible to be included in
the control group.
MRI was performed with a 1.5 T scanner (Siemens, Magne-
tom). MRI was obtained to exclude intracranial pathology and
sinus vein thrombosis as a secondary cause of IIH. A commercially
available surface coil (Siemens) with a diameter of 7 cm was used
in addition to the normal circularly polarized head coil. The
surface coil was placed over one eye within the head coil and fixed
with tape. T2-weighted high-resolution coronal images were
acquired with the surface coil. A fast spin echo (FSE) sequence
with a relaxation time of 6960 msec, an echo time of 99 msec, a
field of view of 85685 mm
2, a matrix size of 2566256 mm
2 (in
plane resolution 3326332 mm
2) and a slice thickness of 2 mm
were performed. The measured time scale was 7 minutes and
20 seconds. The OBV as well as the OS depth were determined
using a standardized method [19]. Computer software Amira 3.2
was used to calculate quantitative morphological parameters.
OBV was investigated by circumnavigating the bulb contours of
all coronal slices starting from the anterior to the posterior border
of the olfactory bulb. The slice thickness was 2 mm, therefore the
OBV could be calculated using the surface areas of each coronal
section through the olfactory bulb (surface area of each coronal
section in mm
2 6count of sections 62 mm). The OS depth was
identified at the level of the last coronal slice through the rearmost
part of the eyeball. The depth of the OS was then calculated by
drawing a straight line tangent to the borders of the straight gyrus
and internal orbital gyrus. From this line an intergyral line to the
deepest point of the OS determined the OS depth (Figure 1). MRI
study readers were blinded to the status and clinical characteristics
of the participating subjects to prevent observer-dependent bias.
Data were presented as mean 6 standard deviation (range) or as
median (range), if they were not normally distributed. The chi-
square test and independent t-test were used to analyse differences
between IIH patients and controls. To determine age-dependent
normal OBV, data proposed by Buschhu ¨ter et al. ($58 mm
3 in
people ,45 years and $46 mm
3 in people .45 years) were used
[15]. Relationships among clinical features of IIH patients, the
OBV, and the depth of OS were examined by using Pearson
correlation coefficient r. A difference was considered significant at
a p-value of ,0.05.
Figure 1. T2-weighted high-resolution coronal images of the olfactory bulb and sulcus olfactorius. Figure 1A and 1B show T2-weighted
fast spin echo (FSE) sequences. In Figure 1A the white arrows indicate the normal dimensioned right and left bulb olfactorius. Figure 1B demonstrates
the calculation of the olfactory sulcus (OS) depth. The distance of the deepest point of the OS was determined using a tangent line from the border of
the gyrus rectus to the internal orbital gyrus.
doi:10.1371/journal.pone.0035221.g001
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Twenty-three patients with IIH and 23 sex, age and BMI
matched controls were included in the study. Twenty participants
of each group were female. Patients had a mean age of 37 years,
and the mean BMI was 33.5 kg/m
2. There was no significant
difference between patients and controls regarding gender, age,
and BMI. Median time between onset of symptoms and begin of
the study was 34 months. Medical history revealed a mean highest
ICP of 37.6 cm CSF in recumbent position. Last measured ICP
was still elevated with a mean of 28.8 cm CSF. The median time
interval between the last measurements of ICP in IIH patients and
the MRI study was 7.6 months. Headache was present in 16
(69.6%) and visual disturbance in 21 (91.3%) patients at the time
of the scan. Sixteen (69.6%) patients were on an IIH treatment
with acetazolamide, topiramate or furosemide (Table 1). Seven
patients were not on medication at time of MRI. All of the
untreated patients were still symptomatic (headache or visual
disturbance present). While mean values of all morphological
parameters were nearly similar in both groups, Pearson correlation
showed that patients with a shorter medical history of IIH revealed
a smaller OBV (r=0.53, p,0.01). In untreated symptomatic
patients (n=7), the effect was greater (r=0.76, p,0.05) (Figure 2).
The significance of the results was maintained after correction for
age of patients. Another analysis revealed that in patients who
suffered from IIH for less than one year (n=8), total OBV was
significantly smaller than in matched controls (116.6624.3 vs.
149.3622.2 mm
3, p=0.01)(Table 1). Seven olfactory bulbs
(43.8%) revealed reduced OBV in the group of patients with
IIH for less than one year, while no matched control subject had a
reduced OBV (p,0.01). Compared with patients who suffered
from IIH for more than one year (n=15) the difference of total
OBVfailedtoreachsignificance(116.6624.3vs. 135.1643.6 mm
3,
p=0.21) and there was no difference in number of reduced
Table 1. Characteristics of participants and results of morphological features of olfactory nerve system.
Patients n=23 (all) Controls n=23 (all)
Significance
p
Patients n=8 (IIH,1
year) Controls n=8 Significance p
Gender, f/m 20/3 20/3 1 7/1 7/1 1
Age, years 37.0613.7(20–63) 37.8612.0(22–61) 0.85 33.569.9(20–48) 33.669.0(22–49) 0.98
BMI, kg/m2 33.567.7(24.1–54.6) 33.667.1(25.5–49.1) 0.96 33.1610.0(25.9–54.6) 33.468.4(25.5–49.1) 0.95
Diagnosis of IIH*, month 34.1(0.4–121.0) – – 2.4 (0.4–12) – –
Headache, n(%) 16(69.6) – – 7(87.5) – –
Visual disturbance, n(%) 21(91.3) – – 6(75) – –
Medication, n(%) 16(69.6) – – 7(87.5) – –
Right OBV, mm
3 63.2621.6(37.0–124.1) 65.6620.3(38.8–128.1) 0.69 55.7615.6(40.1–82.9) 72.3615.9(54.5–98.1) 0.05
Left OBV, mm
3 65.5619.4(38.4–103.0) 64.4616.6(24.0–88.2) 0.84 60.9613.2(38.4–80.3) 70.069.9(66.1–88.2) 0.01
Total OBV, mm
3 128.7±38.4(78.1–
227.1)
130.0±32.6(72.5–
202.8)
0.90 116.6±24.3(78.5–
153.9)
149.3±22.2(124.4–
186.3)
0.01
Right OS, mm 8.661.3(6.3–11.8) 8.861,4(6.3–12.2) 0.69 8.861.9(6.3–11.8) 9.061.1(7.7–11.1) 0.80
Left OS, mm 8.461.4(4.9–11.1) 8.361.3(6.3–10.6) 0.83 8.662.1(4.9–11.1) 8.661.2(6.3–10.1) 0.99
Average OS, mm 8.561.2(5.8–11.5) 8.661.1(6.3–10.8) 0.91 8.761.8(5.8–11.5) 8.860.9(7.0–9.7) 0.89
Numerical data are presented as mean 6 standard deviation (minimum-maximum)*, categorical data as numbers (n) and percent (%). The chi-square test was used for
gender and independent T-test was used for numerical variables. Diagnosis of IIH=time between onset of first symptoms and enrolment in the study. Highest and last
ICP=Highest and last intracranial pressure in the medical history of patients. CSF=Cerebrospinal fluid. Medication = Current intake of acetazolamide, topiramate or
furosemide to treat IIH. OBV=Olfactory bulb volume. OS=Olfactory sulcus. *Numerical data of diagnosis of IIH are presented as median (range: minimum-maximum)
because the data were not normally distributed.
doi:10.1371/journal.pone.0035221.t001
Figure 2. Correlation among clinical features of IIH patients. Left chart, correlation between total OBV and the time between initial diagnosis
of IIH and MRI scan in all IIH patients (n=23). Right chart, Pearson correlation between total olfactory bulb volume (OBV) and the time between initial
diagnosis of IIH and MRI scan in untreated symptomatic patients (n=7).
doi:10.1371/journal.pone.0035221.g002
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median time interval between the last measurements of ICP in
patients with IIH for less than one year and the MRI study was
1 month. Compared to patients who suffer for more than one
year from IIH, last measured ICP was nearly similar compared
to the group with IIH for less than one year (28.067.0 cm vs.
30.462.6 cm CSF, p=0.27). During the period that preceded
study inclusion, the mean ICP decreased significantly in all IIH
patients (37.766.8 vs. 28.965.9 cm CSF, p,0.001). In the
group of untreated symptomatic patients, the ICP was also
decreased during the period prior to inclusion in the study
(36.165.6 vs. 29.567.3 cm CSF, p,0.001).
OS depth was similar in IIH patients and controls to an earlier
published trial of healthy volunteers [14]. IIH patients with visual
disturbances at time of MRI scan (n=21) revealed a lower OS
depth compared to patients without visual disturbances (8.360.9
vs. 10.861.0, p,0.01). No other significant correlations were
found.
Discussion
The aim of our pilot study was to investigate whether patients
with IIH exhibit morphological changes of the ON system. From
the pathophysiological point of view, it is conceivable that elevated
ICP could compromise the ON. Furthermore, an extensive
lymphatic network system around the olfactory nerves seems to
play a potential role in CSF absorption. Altered lymphatic
dynamics within the nasal compartment may at least partially
contribute to ON changes.
We investigated 23 IIH patients and 23 matched controls. The
median time interval between diagnosis of IIH and MRI was 34
months and around 70% of IIH patients were treated. This might
be responsible for finding no difference between the main groups
of our pilot study. Short duration of IIH was associated with
smaller amounts of total OBV even in untreated symptomatic
patients. All IIH patients had a history of significantly reduced ICP
during the period that preceded study inclusion. This might be
caused by the course of disease in combination with the
pharmacotherapy. Therapeutic weight loss and therapeutic
lumbar punctures should be also taken under consideration, even
in untreated IIH patients without pharmacotherapy at time of
MRI. Due to the considerable regenerative ONS potential
[20,21], it is conceivable that its reconstitution might have already
been induced by subtle ICP decreases. Changes of the ONs could
therefore be expected in an earlier stage of IIH which is frequently
associated with higher ICP levels.
Our study revealed a number of limitations. The time interval
between last ICP measurements in all patients and MRI was with
7.6 months too long. In an optimal setting it should be shorter.
However, from an ethical point of view it would be questionable to
perform another lumbar puncture in order to improve the design.
The group patients with duration of IIH for less than one year
revealed significantly reduced OBV compared to matched
controls. In the smaller IIH group of eight patients the median
time interval between last ICP measurements and MRI was with
one month markedly shorter.
The distribution of sex, age and BMI (female to male ratio: 20:3,
mean age: 37 years, mean BMI: 33.5 kg/m
2) in our study is
comparable to other study cohorts. Boll et al. reported in a review
that IIH is most common in women and obese individuals. The
published female to male ratios range from 4:1 to 15:1 and the
frequenciesofobesityinIIHpatientsare71%,88%,91%,and94%
[1]. Dhungana and colleagues indicated in a review that IIH most
commonly affects overweight women between the ages of 15 and
45 years [2]. Out of 71 potentially eligible IIH patients 23 were
included. 15 patients were excluded by the predefined exclusion
criteria like conditions after shunt surgery or MRI phobia. A large
proportion of the potentially eligible IIH patients could not be
contactedbyphoneorparticipationexpenseweretoohighforthem.
Taking this into account, we cannot rule out the probability that
patients with reduced social activities or even with depression might
have refused participation in the study. Nevertheless, subjects
suffering from depression for example tend to present more often
witholfactorydisordersascomparedtothegeneralpopulation[22].
Among other things, OBV is dependent from neuroblast migration
fromthelateralventricularextensionoftheforebrain.OBVseemsto
bedependentoninputofsmellinganditcouldbedemonstratedthat
migration velocity depends on sensory input [20,23].
Our pilot study suggests the possibility that morphological
changes of the ON system could be present in IIH patients,
especially with a short duration of disease. As it is well known that
the OBV decreases with increasing age [15], it is unlikely that we
have presented a natural course of aging. Nevertheless, a
prospective longitudinal study design starting from the onset of
the disease is required to confirm our results.
Patients with visual disturbance revealed a lower depth of OS.
Whether the reduced OS depth in patients with visual distur-
bances is functionally relevant, remains unclear. Increased ICP or
disturbed CSF dynamics could lead to a morphological alteration
without functional correlate. Olfactory testing is necessary to
answer the question, whether patients with IIH suffer from
hyposmia, especially in the early stages of disease. The UPSIT
(University of Pennsylvania Smell Identification Test) or the TDI
(threshold, discrimination and identification) test using ‘‘sniffin’
sticks’’ [24,25] could be useful tools to clarify this question.
Although, decreased olfactory function is associated with reduced
olfactory bulb volume (OBV) [12,13,14,15], testing of olfactory
capacity can not be replaced by the measurements of OBV or OS
depth. Therefore, further trials are required to investigate the
olfactory system in IIH patients.
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